Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117749

Molecular basis of CD36 deficiency. Evidence that a 478C-->T substitution (proline90-->serine) in CD36 cDNA accounts for CD36 deficiency.

H Kashiwagi, Y Tomiyama, S Honda, S Kosugi, M Shiraga, N Nagao, S Sekiguchi, Y Kanayama, Y Kurata, and Y Matsuzawa

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Kashiwagi, H. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Tomiyama, Y. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Honda, S. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Kosugi, S. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Shiraga, M. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Nagao, N. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Sekiguchi, S. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Kanayama, Y. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Kurata, Y. in: PubMed | Google Scholar

Second Department of Internal Medicine, Osaka University Medical School, Japan.

Find articles by Matsuzawa, Y. in: PubMed | Google Scholar

Published March 1, 1995 - More info

Published in Volume 95, Issue 3 on March 1, 1995
J Clin Invest. 1995;95(3):1040–1046. https://doi.org/10.1172/JCI117749.
© 1995 The American Society for Clinical Investigation
Published March 1, 1995 - Version history
View PDF
Abstract

CD36 deficiency is divided into two subgroups: neither platelets nor monocytes express CD36 (type I deficiency), and monocytes express CD36 in spite of the lack of platelet CD36 (type II deficiency). We have already demonstrated that a 478C-->T substitution (proline90-->serine) in platelet CD36 cDNA predominates in type II deficiency (Kashiwagi, H., S. Honda, Y. Tomiyama, H. Mizutani, H. Take, Y. Honda, S. Kosugi, Y. Kanayama, Y. Kurata, and Y. Matsuzawa. 1993. Thromb. Haemostasis. 69:481-484). In this study, we revealed that monocyte CD36 cDNA from two type II deficient subjects was heterozygous for C478 and T478 form, while platelet CD36 cDNA of these subjects consisted of only T478 form. In a type I deficient subject, both platelet and monocyte CD36 cDNA showed only T478 form. Expression assay using C478 or T478 form of CD36 cDNA transfected cells revealed that there was an 81-kD precursor form of CD36, and that the maturation of the 81-kD precursor form to the 88-kD mature form of CD36 was markedly impaired by the substitution. The mutated precursor form of CD36 was subsequently degraded in the cytoplasm. These results indicate that the 478C-->T substitution directly leads to CD36 deficiency via defects in posttranslational modification, and that this substitution is the major defects underlying CD36 deficiency.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1040
page 1040
icon of scanned page 1041
page 1041
icon of scanned page 1042
page 1042
icon of scanned page 1043
page 1043
icon of scanned page 1044
page 1044
icon of scanned page 1045
page 1045
icon of scanned page 1046
page 1046
Version history
  • Version 1 (March 1, 1995): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts